Controlled release of vascular endothelial growth factor using poly-lactic-co-glycolic acid microspheres: In vitro characterization and application in polycaprolactone fumarate nerve conduits

Acta Biomaterialia

Volumn 8, Issue 2, 2012, Pages 511-518

  Rui, Jing ^a,b   Dadsetan, Mahrokh ^a   Runge, M Brett ^a   Spinner, Robert J ^a   Yaszemski, Michael J ^a   Windebank, Anthony J ^a   Wang, Huan ^a,b  

^a MAYO CLINIC   (United States)

^b FUDAN UNIVERSITY   (China)

Author keywords

Bioactivity; Biodegradation; Microsphere; Poly lactic co glycolic acid; Vascular endothelial growth factor

Indexed keywords

BIOACTIVITY; BIODEGRADATION; EMULSIFICATION; ENCAPSULATION; ENDOTHELIAL CELLS;

CONTROLLED RELEASE; IN-VITRO; IN-VIVO; NERVE CONDUITS; NERVE REGENERATION; POLY LACTIC-CO-GLYCOLIC ACID; POLY(LACTIC-CO-GLYCOLIC ACID); POLY(LACTICCO-GLYCOLIC ACID) MICROSPHERE; VASCULAR ENDOTHELIAL GROWTH FACTOR; VITRO CHARACTERIZATION;

MICROSPHERES;

MICROSPHERE; POLYCAPROLACTONE; POLYCAPROLACTONE FUMARATE; POLYGLACTIN; SOLVENT; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; EMULSION; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EVAPORATION; HUMAN; HUMAN CELL; MATERIALS TESTING; NERVE GROWTH; NERVE REGENERATION; PRIORITY JOURNAL; UMBILICAL VEIN;

EID: 84855469882     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2011.10.001     Document Type: Article

References (42)

1. A. Nilsson, L. Dahlin, G. Lundborg, and M. Kanje Graft repair of a peripheral nerve without the sacrifice of a healthy donor nerve by the use of acutely dissociated autologous Schwann cells Scand J Plast Reconstr Surg Hand Surg 39 2005 1 6 (Pubitemid 40314637)
2. S. Yla-Herttuala, T.T. Rissanen, I. Vajanto, and J. Hartikainen Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine J Am Coll Cardiol 49 2007 1015 1026 (Pubitemid 46349500)
3. M. Gnecchi, H. He, N. Noiseux, O.D. Liang, L. Zhang, and F. Morello Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement FASEB J 20 2006 661 669 (Pubitemid 44933310)
4. Y.S. Ng, and P.A. D'Amore Therapeutic angiogenesis for cardiovascular disease Curr Control Trials Cardiovasc Med 2 2001 278 285 (Pubitemid 34100479)
5. R.C. Hendel, T.D. Henry, K. Rocha-Singh, J.M. Isner, D.J. Kereiakes, and F.J. Giordano Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect Circulation 101 2000 118 121 (Pubitemid 30044247)
6. M. Hedman, J. Hartikainen, M. Syvanne, J. Stjernvall, A. Hedman, and A. Kivela Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT) Circulation 107 2003 2677 2683 (Pubitemid 36667240)
7. K. Makinen, H. Manninen, M. Hedman, P. Matsi, H. Mussalo, and E. Alhava Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study Mol Ther 6 2002 127 133 (Pubitemid 36124280)
8. T.T. Rissanen, J.E. Markkanen, K. Arve, J. Rutanen, M.I. Kettunen, and I. Vajanto Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model FASEB J 17 2003 100 102
9. M. Simons, B.H. Annex, R.J. Laham, N. Kleiman, T. Henry, and H. Dauerman Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial Circulation 105 2002 788 793 (Pubitemid 34174916)
10. T.D. Henry, B.H. Annex, G.R. McKendall, M.A. Azrin, J.J. Lopez, and F.J. Giordano The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis Circulation 107 2003 1359 1365 (Pubitemid 36350732)
11. S. Rajagopalan, E.R. Mohler, R.J. Lederman, F.O. Mendelsohn, J.F. Saucedo, and C.K. Goldman Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication Circulation 108 2003 1933 1938 (Pubitemid 37296537)
12. J. Kastrup, E. Jorgensen, A. Ruck, K. Tagil, D. Glogar, and W. Ruzyllo Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris. A randomized double-blind placebo-controlled study: the Euroinject one trial J Am Coll Cardiol 45 2005 982 988 (Pubitemid 40432426)
13. M.A. Tria, M. Fusco, G. Vantini, and R. Mariot Pharmacokinetics of nerve growth factor (NGF) following different routes of administration to adult rats Exp Neurol 127 1994 178 183 (Pubitemid 24247961)
14. L.A. Pfister, M. Papaloizos, H.P. Merkle, and B. Gander Nerve conduits and growth factor delivery in peripheral nerve repair J Peripher Nerv Syst 12 2007 65 82 (Pubitemid 46906328)
15. F. Quaglia Bioinspired tissue engineering: the great promise of protein delivery technologies Int J Pharm 364 2008 281 297
16. D.H. Kempen, L. Lu, X. Zhu, C. Kim, E. Jabbari, and W.J. Dhert Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation J Biomed Mater Res A 70 2004 293 302 (Pubitemid 38988759)
17. S. Wang, M.J. Yaszemski, A.M. Knight, J.A. Gruetzmacher, A.J. Windebank, and L. Lu Photo-crosslinked poly(epsilon-caprolactone fumarate) networks for guided peripheral nerve regeneration: material properties and preliminary biological evaluations Acta Biomater 5 2009 1531 1542
18. P.C. O'Brien, and M.A. Shampo Statistical considerations for performing multiple tests in a single experiment. 5. Comparing two therapies with respect to several endpoints Mayo Clin Proc 63 1988 1140 1143
19. G. Penkert, W. Bini, and M. Samii Revascularization of nerve grafts: an experimental study J Reconstr Microsurg 4 1988 319 325
20. K.A. Houck, D.W. Leung, A.M. Rowland, J. Winer, and N. Ferrara Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms J Biol Chem 267 1992 26031 26037 (Pubitemid 23014012)
21. C.J. Robinson, and S.E. Stringer The splice variants of vascular endothelial growth factor (VEGF) and their receptors J Cell Sci 114 2001 853 865 (Pubitemid 32273121)
22. B. Barleon, S. Sozzani, D. Zhou, H.A. Weich, A. Mantovani, and D. Marme Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 Blood 87 1996 3336 3343 (Pubitemid 26115364)
23. R. de Boer, A.M. Knight, R.J. Spinner, M.J. Malessy, M.J. Yaszemski, and A.J. Windebank In vitro and in vivo release of nerve growth factor from biodegradable poly-lactic-co-glycolic-acid microspheres J Biomed Mater Res A 95 2010 1067 1073
24. J.M. Kim, K.S. Seo, Y.K. Jeong, B.L. Hai, Y.S. Kim, and G. Khang Co-effect of aqueous solubility of drugs and glycolide monomer on in vitro release rates from poly(D, L-lactide-co-glycolide) discs and polymer degradation J Biomater Sci Polym Ed 16 2005 991 1007 (Pubitemid 41038823)
25. D.T. Birnbaum, and L. Brannon-Peppas Molecular weight distribution changes during degradation and release of PLGA nanoparticles containing epirubicin HCl J Biomater Sci Polym Ed 14 2003 87 102 (Pubitemid 36267558)
26. S.P. Ayalasomayajula, and U.B. Kompella Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model Eur J Pharmacol 511 2005 191 198 (Pubitemid 40417726)
27. A.E. Elcin, and Y.M. Elcin Localized angiogenesis induced by human vascular endothelial growth factor-activated PLGA sponge Tissue Eng 12 2006 959 968 (Pubitemid 43726536)
28. T.Y. Lim, C.K. Poh, and W. Wang Poly(lactic-co-glycolic acid) as a controlled release delivery device J Mater Sci Mater Med 20 2009 1669 1675
29. F.R. Formiga, B. Pelacho, E. Garbayo, G. Abizanda, J.J. Gavira, and T. Simon-Yarza Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model J Control Release 147 2010 30 37
30. J.S. Golub, Y.T. Kim, C.L. Duvall, R.V. Bellamkonda, D. Gupta, and A.S. Lin Sustained VEGF delivery via PLGA nanoparticles promotes vascular growth Am J Physiol Heart Circ Physiol 298 2010 H1959 H1965
31. C. Borselli, F. Ungaro, O. Oliviero, I. d'Angelo, F. Quaglia, and M.I. La Rotonda Bioactivation of collagen matrices through sustained VEGF release from PLGA microspheres J Biomed Mater Res A 92 2010 94 102
32. X. Cao, and M.S. Schoichet Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders Biomaterials 20 1999 329 339
33. L.W. Norton, E. Tegnell, S.S. Toporek, and W.M. Reichert In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings Biomaterials 26 2005 3285 3297 (Pubitemid 39647262)
34. A.Z. Faranesh, M.T. Nastley, C. Perez de la Cruz, M.F. Haller, P. Laquerriere, and K.W. Leong In vitro release of vascular endothelial growth factor from gadolinium-doped biodegradable microspheres Magn Reson Med 51 2004 1265 1271 (Pubitemid 38797013)
35. J. Lee, S.H. Bhang, H. Park, B.S. Kim, and K.Y. Lee Active blood vessel formation in the ischemic hindlimb mouse model using a microsphere/hydrogel combination system Pharm Res 27 2010 767 774
36. M. Lee, T.T. Chen, M.L. Iruela-Arispe, B.M. Wu, and J.C. Dunn Modulation of protein delivery from modular polymer scaffolds Biomaterials 28 2007 1862 1870 (Pubitemid 46123542)
37. D.H. Kempen, L. Lu, X. Zhu, C. Kim, E. Jabbari, and W.J. Dhert Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. I. Preparation and characterization J Biomed Mater Res A 70 2004 283 292 (Pubitemid 38992325)
38. T.W. King, and C.W. Patrick Jr Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique J Biomed Mater Res 51 2000 383 390 (Pubitemid 30452141)
39. M. Iwata, Y. Nakamura, and J.W. McGinity Particle size and loading efficiency of poly(D, L-lactic-co-glycolic acid) multiphase microspheres containing water soluble substances prepared by the hydrous and anhydrous solvent evaporation methods J Microencapsul 16 1999 49 58 (Pubitemid 29045851)
40. A. Gopferich Mechanisms of polymer degradation and erosion Biomaterials 17 1996 103 114 (Pubitemid 26031366)
41. J. Lee, and K.Y. Lee Local and sustained vascular endothelial growth factor delivery for angiogenesis using an injectable system Pharm Res 26 2009 1739 1744
42. S.L. Franklin, R.J. Ferry Jr, and P. Cohen Rapid insulin-like growth factor (IGF)-independent effects of IGF binding protein-3 on endothelial cell survival J Clin Endocrinol Metab 88 2003 900 907 (Pubitemid 36207840)